Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial

NCT00272480 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

HTLV-I-associated Myelopathy

Interventions

DRUG: Zidovudine/lamivudine
DRUG: Placebos

Sponsor

Imperial College London